Analysis of interleukin-10 gene polymorphisms and hepatitis C susceptibility in Pakistan

Journal of Infection in Developing Countries

Volumn 5, Issue 6, 2011, Pages 473-479

  Afzal, Muhammad Sohail ^a   Tahir, Sadia ^a   Salman, Amna ^a   Baig, Tahir Ahmed ^a   Shafi, Talha ^a   Zaidi, Najm Us Sahar Sadaf ^a   Qadri, Ishtiaq ^a  

^a NATIONAL UNIVERSITY OF SCIENCES AND TECHNOLOGY   (Pakistan)

Author keywords

HCV; IL 10; Polymorphism

Indexed keywords

INTERLEUKIN 10;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; HAPLOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PAKISTAN; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

HEPATITIS C VIRUS;

EID: 79960125031     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.1338     Document Type: Article

References (33)

1. Wands JR (2004) Prevention of hepatocellular carcinoma. N Engl J Med 351: 1567-1570.
2. Waheed Y, Shafi T, Safi SZ, Qadri I (2009) Hepatitis C virus in Pakistan: A systematic review of prevalence, genotypes and risk factors. World J Gastroenterol 15: 5647-5653.
3. Minton EJ, Smillie D, Smith P, Shipley S, McKendrick MW, Gleeson DC, Underwood JC, Cannings C, Wilson AG (2005) Clearance of hepatitis C virus is not associated with single nucleotide polymorphisms in the IL-1,-6, or-10 genes. Hum Immunol 66: 127-132.
4. Rehermann B and Nascimbeni M (2005) Immunology of hepatitis b virus and hepatitis c virus infection. Nat Rev 5: 215-229.
5. Oleksyk TK, Thio CL, Truelove AL, Goedert JJ, Donfield SM, Kirk GD, Thomas DL, O'Brien SJ, Smith MW (2005) Single nucleotide polymorphisms and haplotypes in the IL-10 region associated with HCV clearance. Genes Immun 6: 347-357.
6. Bouzgarrou N, Hassen E, Farhat K, Bahri O, Gabbouj S, Maamouri N, Ben Mami N, Saffar H, Trabelsi A, Triki H, Chouchane L (2009) Combined analysis of interferon-γ and interleukin-10 gene polymorphisms and chronic hepatitis C severity. Hum Immunol 70: 230-236.
7. Rehermann B (2000) Interaction between the hepatitis C virus and the immune system. Semin Liver Dis 20: 127-141.
8. Kakizaki S, Takagi H, Yamazaki Y, Sohara N, Sato K, Nagamine T, Masatomo M (2006) Different outcomes of nosocomial infection with hepatitis C virus from the same origin. World J Gastroenterol 12: 659-661.
9. Ollier WE (2004) Cytokine genes and disease susceptibility. Cytokine 28: 174-178.
10. Thio C (2008) Host Genetic Factors and Antiviral Immune Responses to HCV. Clin Liver Dis 12: 713-726.
11. Gaurav D and Anita C (2009) To determine the polymorphism of tumor necrosis factor-alpha and interleukin-10 genes in chronic hepatitis C patients. Indian Journal of Virology 20:1. Print ISSN: 0970-2822. Online ISSN: 0974-0120.
12. Reuss E, Fimmers R, Kruger A, Becker C, Rittner C, Hohler T (2002) Differential regulation of interleukin-10 production by genetic and environmental factors: a twin study. Genes Immun 3: 407-413.
13. Koss K, Satsangi J, Fanning GC, Welsh KI, Jewell DP (2000) Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies. Genes Immun 1: 185-190.
14. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24:1-8.
15. Perrey C, Turner ST, Pravica V, Howell WM, Hutchinson IV (1998) ARMS-PCR methodologies to determine IL-10, TNF. a, TNF-B and TGF-B1 gene polymohlsms. Transplant Immunology 7: 127-128.
16. Persico M, De Renzo A, Persico E, Torella D, Rotoli B, Torella R (1998) Chronic liver disease and lymphoproliferative disorders in HCV-positive patients: a working hypothesis. J Hepatol 29: 857-859.
17. Ollier WE (2004) Cytokine genes and disease susceptibility. Cytokine 28: 174-178.
18. Hohler T, Reuss E, Freitag CM, Schneider PM (2005) A functional polymorphism in the IL-10 promoter influences the response after vaccination with HBsAg and hepatitis A. Hepatology 42: 72-76.
19. Yee LJ, Tang J, Gibson AW, Kimberly R, Van Leeuwen DJ, Kaslow RA (2001) Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. Hepatology 33: 708-712.
20. Vidigal PG, Germer JJ, Zein NN (2002) Polymorphisms in the interleukin-10, tumor necrosis factor-alpha, and transforming growth factor-beta1 genes in chronic hepatitis C patients treated with interferon and ribavirin. J Hepatol 36: 271-277.
21. Abe H, Aizawa Y, Takahashi H, Amano K, Zeniya M (2003) Single Nucleotide Polymorphisms in the Interleukin-10 Gene Promoter and Clinical Outcome of Chronic Hepatitis C Virus Infection. Jikeikai Med J 50: 159-166.
22. Persico M, Capasso M, Persico E, Masarone M, De Renzo A, Spano D, Savino Bruno, Iolascon A (2006) Interleukin-10-1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection. J Hepatol 45: 779-785.
23. Gao QJ, Liu DW, Zhang SY, Jia M, Wang LM, Wu LH, Wang SY, Tong LX (2009) Polymorphisms of some cytokines and chronic hepatitis B and C virus infection. World J Gastroenterol 15 (44): 5610-5619.
24. Constantini PK, Wawrzynowicz-Syczewska M, Clare M, Boron-Kaczmarska A, McFarlane IG, Cramp ME, Donaldson PT (2002) Interleukin-1, interleukin-10 and tumour necrosis factor-alpha gene polymorphisms in hepatitis C virus infection: an investigation of the relationships with spontaneous viral clearance and response to alpha-interferon therapy. Liver 22: 404-412.
25. Lio D, Caruso C, Di Stefano R, Colonna Romano G, Ferraro D, Scola L, Crivello A, Licata A, Valenza LM, Candore G, Craxì A, Almasio PL (2003) IL-10 and TNF-a Polymorphisms and the Recovery From HCV Infection. Hum Immunol 64: 674-680.
26. Knapp S, Hennig BJ, Frodsham AJ, Zhang L, Hellier S, Wright M, Goldin R, Hill AV, Thomas HC, Thursz MR (2003) Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection. Immunogenetics 55:362-369.
27. Kusumoto K, Uto H, Hayashi K, Takahama Y, Nakao H, Suruki R, Stuver SO, Ido A, Tsubouchi H (2006) Interleukin-10 or tumor necrosis factor-α polymorphisms and the natural course of hepatitis C virus infection in a hyperendemic area of Japan. Cytokine 34: 24-31.
28. Tso HW, Ip WK, Chong WP, Tam CM, Chiang AKS, Lau YL (2005) Association of interferon gamma and interleukin 10 genes with tuberculosis in Hong Kong Chinese. Genes Immun 6: 358-363.
29. Shin HD, Park BL, Kim LH, Jung JH, Kim JY, Yoon JH, Kim YJ, Lee H (2003) Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. Hum Mol Genet 12: 901-906.
30. Mangia A, Santoro R, Piattelli M, Pazienza V, Grifa G, Iacobellis A, Andriulli A (2004) IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection. Cytokine 25: 103-109.
31. Abbas Z and Moatter T (2003) Interleukin (IL) 1 beta and IL-10 gene polymorphism in chronic hepatitis C patients with normal or elevated alanine aminotransferase levels. J Pak Med Assoc 53: 59-62.
32. Abbas Z, Moatter T, Hussainy A, Jafri W (2005) Effect of cytokine gene polymorphism on histological activity index, viral load and response to treatment in patients with chronic hepatitis C genotype 3. World J Gastroenterol 11: 6656-6661.
33. Fickenscher H, Hor S, Kupers H, Knappe A, Wittmann S, Sticht H (2002) The interleukin-10 family of cytokines. Trends Immunol 23: 89-96.